• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: THORATEC SWITZERLAND GMBH CENTRIMAG 2ND GENERATION PRIMARY CONSOLE; CONTROL, PUMP SPEED, CARDIOPULMONARY BYPASS

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

THORATEC SWITZERLAND GMBH CENTRIMAG 2ND GENERATION PRIMARY CONSOLE; CONTROL, PUMP SPEED, CARDIOPULMONARY BYPASS Back to Search Results
Model Number 201-90411
Device Problems Infusion or Flow Problem (2964); Insufficient Information (3190)
Patient Problems Low Oxygen Saturation (2477); No Clinical Signs, Symptoms or Conditions (4582)
Event Date 12/14/2021
Event Type  Injury  
Manufacturer Narrative
No further information was provided.A supplemental report will be submitted once the manufacturer's investigation is complete.
 
Event Description
It was reported that the patient's flow suddenly dropped to 0 lpm and sustained for several seconds.The patient became symptomatic with low blood oxygen levels.The centrimag console displayed both flow and pressure were below their minimum values.The site emergently switched to a backup console and the issue resolved.The patient became stable.Centrimag motor mfr #: 3003306248-2021-07043.
 
Manufacturer Narrative
Section d6a: expiration date was inadvertently included in the initial report but is not applicable for this device.Manufacturer's investigation conclusion: the reported event of a drop in flow and flow and pressure below minimum alarms were confirmed via customer submitted photos.The centrimag 2nd generation primary console (serial #: (b)(6)) was returned for analysis and a log file was downloaded for review.A review of the downloaded log file showed events spanning approximately 3 days ((b)(6) 2021 ¿ (b)(6) 2021, (b)(6) 2022 per time stamp).Events occurring on (b)(6) 2022 took place during lab testing at abbott.There were no notable events active in the log file.The motor and pump were not connected within the log file.The centrimag 2nd generation primary console was returned for analysis to the service depot and the reported event was unable to be reproduced.The console was connected to a test loop and run for several days with no alarms.The console was opened for an internal inspection and no anomalies were observed.A full functional test was performed, and all tests were passed.The root cause for the reported event was unable to be conclusively determined through this analysis.The device history records were reviewed for the centrimag 2nd generation primary console (serial #: (b)(6)) and the console was found to pass all manufacturing and qa specifications.The 2nd generation centrimag system operating manual (rev.Lm) section 4 entitled "warnings & precautions" warns "one additional 2nd generation centrimag primary console, motor and flow probe are required as backup system in the immediate vicinity of each patient whenever the centrimag or pedivas blood pump is used.The backup console must be connected to the backup motor and to the backup flow probe, have a battery charge sufficient for at least one hour of operation, be connected to ac power (except during transport) and be immediately available should the main console, motor or flow probe experience a malfunction." the 2nd generation centrimag system operating manual (rev.M) section 10 entitled "emergency and troubleshooting" states that "the recommended practice whenever there is a 2nd generation centrimag primary console or motor malfunction is to replace the console and motor as a set.Remove the blood pump from the malfunctioning motor and console and place the blood pump in the backup motor and console to continue patient support.Do not exchange individual motors or individual consoles during patient support." the 2nd generation centrimag system operating manual (rev.M) table 13 entitled ¿console alarms & alerts¿ details the various alarms and alerts and the appropriate operator response, including f3 and p4 alarms.No further information was provided.The manufacturer is closing the file on this event.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
CENTRIMAG 2ND GENERATION PRIMARY CONSOLE
Type of Device
CONTROL, PUMP SPEED, CARDIOPULMONARY BYPASS
Manufacturer (Section D)
THORATEC SWITZERLAND GMBH
technoparkstrasse 1
zurich CH-80 05
SZ  CH-8005
Manufacturer (Section G)
THORATEC SWITZERLAND GMBH
technoparkstrasse 1
zurich CH-80 05
SZ   CH-8005
Manufacturer Contact
bob fryc
6035 stoneridge drive
pleasanton, CA 94588
7818528204
MDR Report Key13206154
MDR Text Key287928474
Report Number3003306248-2021-07044
Device Sequence Number1
Product Code DWA
UDI-Device Identifier07640135140702
UDI-Public7640135140702
Combination Product (y/n)N
Reporter Country CodeUS
PMA/PMN Number
K131179
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Health Professional,Company Representative
Reporter Occupation Nurse
Type of Report Initial,Followup
Report Date 04/01/2022
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Health Professional
Device Expiration Date03/31/2022
Device Model Number201-90411
Device Lot Number7452170
Was Device Available for Evaluation? Device Returned to Manufacturer
Is the Reporter a Health Professional? Yes
Was the Report Sent to FDA? No
Initial Date Manufacturer Received 12/15/2021
Initial Date FDA Received01/10/2022
Supplement Dates Manufacturer Received03/28/2022
Supplement Dates FDA Received04/01/2022
Was Device Evaluated by Manufacturer? Yes
Date Device Manufactured09/06/2019
Is the Device Single Use? No
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Unknown
Patient Sequence Number1
Patient Outcome(s) Required Intervention;
Patient Age55 YR
Patient SexFemale
Patient Weight79 KG
-
-